Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
46,821,220
-
Number of holders
-
7
-
Total 13F shares, excl. options
-
3,520,885
-
Shares change
-
-573,224
-
Total reported value, excl. options
-
$28,772,000
-
Value change
-
-$6,268,938
-
Number of sells
-
-5
-
Price
-
$8.1
Significant Holders of Nanobiotix S.A. - Common Stock (NBTX) as of Q4 2021
9 filings reported holding NBTX - Nanobiotix S.A. - Common Stock as of Q4 2021.
Nanobiotix S.A. - Common Stock (NBTX) has 7 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3,520,885 shares
of 46,821,220 outstanding shares and own 7.52% of the company stock.
Largest 9 shareholders include BAILLIE GIFFORD & CO (1,400,000 shares), PERCEPTIVE ADVISORS LLC (1,059,800 shares), Artal Group S.A. (1,000,000 shares), Woodline Partners LP (42,572 shares), MILLENNIUM MANAGEMENT LLC (12,217 shares), UBS Group AG (6,013 shares), Activest Wealth Management (283 shares), MORGAN STANLEY (0 shares), and ORBIMED ADVISORS LLC (0 shares).
This table shows the top 7 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.